Executive Summary
FMCG sector filings highlight earnings season kickoff with strong FY26 results from key players like HUL (8% Q4 revenue growth YoY, 5% FY USG) and Britannia (6.7% FY revenue growth YoY, 16.5% net profit growth), contrasted by Q4 softness in Britannia (-5.1% revenue QoQ) and Emami's target IncNut showing revenue declines (-15.3% YoY FY24, -10.9% FY25). Capital allocation remains shareholder-friendly with Dabur recommending Rs 5.50 final dividend (550%) and Britannia Rs 90.50, signaling stable cash flows amid labor cost pressures (Britannia employee expenses +16.9% YoY). M&A activity surges with Emami's Rs 321 Cr acquisition of 60% in personalized beauty firm IncNut (closing within 30 days), reinforcing digital BPC push despite target's declining turnover. ITC advances subsidiary mergers (effective June 1, 2026) and schedules board meeting May 21 for FY26 results/dividend. Neutral sentiment dominates procedural filings (earnings calls, board meets), but positive tones on growth execution (HUL direct reach +2L outlets) and strategic buys outweigh mixed signals from JV losses (Dabur ~Rs 1.8 Cr immaterial) and target weaknesses. Portfolio-level: 3/5 reporting companies show FY revenue growth >6% YoY, but Q4 QoQ dips flag seasonal demand risks; upcoming catalysts cluster in May-July (board meets, record dates). Actionable: Favor HUL/Dabur for growth/dividends, monitor Emami integration.
Tracking the trend? Catch up on the prior BSE FMCG Sector Regulatory Filings digest from May 01, 2026.
Investment Signals(12)
- Dabur India↓(BULLISH)▲
Audited FY26 results with unmodified opinion, recommended Rs 5.50 final dividend (550% on Rs 1 FV), AGM Aug 6, record date Jul 17; consistent across 6 filings signaling strong governance and returns
- Hindustan Unilever↓(BULLISH)▲
Q4 FY26 cons revenue +8% YoY (7% USG, highest in 12Q), EBITDA +6% YoY at 23.7% margin (top of guidance), FY turnover Rs 63,763 Cr (+5% USG vs FY25 2%), Beauty & Wellbeing portfolio x4 YoY
- Britannia Industries↓(BULLISH)▲
FY26 cons revenue +6.7% YoY to Rs 19,152 Cr, net profit +16.5% YoY to Rs 2,537 Cr (standalone Rs 2,562 Cr), net cash ops +5% YoY to Rs 2,612 Cr, final dividend Rs 90.50
- Emami↓(BULLISH)▲
Acquired 60% stake in IncNut Digital (Vedix/SkinKraft brands) for up to Rs 321 Cr, complements The Man Company/Brillare, high-growth personalized BPC entry, remaining stake in 4.5 yrs performance-linked
- ITC↓(BULLISH)▲
Subsidiary amalgamations (Sresta/Wimco) sanctioned by NCLT, effective Jun 1 2026, adds UAE/USA subs wholly-owned, all scheme conditions met
- Radico Khaitan↓(BULLISH)▲
Q4/FY26 earnings call recording available, post-audited results disclosure, neutral but timely access to mgmt commentary
- United Breweries↓(BULLISH)▲
Q4 FY26 earnings call recording released May 6, compliant disclosure enables investor review of performance trends
- Dabur India↓(BULLISH)▲
JV net loss Rs 1.8 Cr immaterial to group, mgmt approved as non-material, unmodified audit opinion across cons/standalone FY26 results
- HUL(BULLISH)▲
Home Care liquids >Rs 4,000 Cr turnover with double-digit growth/market share gains, direct GT coverage +2 lakh outlets FY26
- Britannia↓(BULLISH)▲
Total assets +10% YoY to Rs 9,732 Cr, supports capacity expansion amid 16.9% employee expense rise from labor codes
- Emami↓(BULLISH)▲
No regulatory approvals needed for IncNut deal, not related party, execution of subscription/purchase agreement May 7
- ITC↓(BULLISH)▲
Board meeting May 21 for FY26 audited results incl segments/balance sheet/cash flows + final dividend recommendation
Risk Flags(8)
- Britannia/Q4 Weakness↓[HIGH RISK]▼
Q4 revenue -5.1% QoQ to Rs 4,719 Cr (from Rs 4,970 Cr), other op revenues -28.1% YoY to Rs 293 Cr, potential demand slowdown
- Emami/Target Declines↓[MEDIUM RISK]▼
IncNut turnover -15.3% YoY FY23-24 (Rs 232 Cr to 197 Cr), -10.9% FY24-25 to Rs 175 Cr, integration risks in declining asset
- Britannia/Cost Pressures↓[MEDIUM RISK]▼
Employee benefits expense +16.9% YoY to Rs 824 Cr due to labor code impacts, could pressure FY27 margins
- Dabur/JV Exposure↓[LOW RISK]▼
Group share of JV net loss ~Rs 1.8 Cr (unaudited but mgmt deems immaterial), watch for recurring drags
- Sector/Seasonal Dip[MEDIUM RISK]▼
1/2 reporting cos (Britannia) show Q4 QoQ revenue decline amid stable demand noted by HUL, broader FMCG volume risks
- Kilitch Drugs/Upcoming Results↓[MEDIUM RISK]▼
Board meet May 15 for FY26 results, trading window closed since Apr 1, potential volatility pre-disclosure
- Emami/Deal Timeline↓[MEDIUM RISK]▼
IncNut acquisition completion within 30 days (by Jun 6), performance-linked adjustments over 24 months add execution uncertainty
- ITC/Pre-Results↓[LOW RISK]▼
No FY26 figures yet ahead of May 21 board meet, historical segment pressures could emerge
Opportunities(10)
- Dabur/Dividend Play↓(OPPORTUNITY)◆
Rs 5.50 final div (550%), record Jul 17, book closure Jul 20-24, payment by Sep 4 if approved; stable payout in growing FMCG
- HUL/Growth Acceleration(OPPORTUNITY)◆
FY26 USG 5% (UVG 4%) vs FY25 2%, Q4 7% USG highest in 12Q, portfolio transformation undervalued vs peers
- Emami/BPC Expansion↓(OPPORTUNITY)◆
Rs 321 Cr for 60% IncNut (personalized beauty), scales innovation post-Zandu/Kesh King, high-growth D2C complements
- Britannia/FY Strength↓(OPPORTUNITY)◆
Net profit +16.5% YoY despite Q4 dip, cash ops Rs 2,612 Cr supports dividend Rs 90.50 (record Jul 31, AGM Aug 7)
- ITC/Merger Simplification↓(OPPORTUNITY)◆
Sresta/Wimco amalgamation effective Jun 1 adds global subs (UAE/USA), potential EPS accretion post-integration
- HUL/Margin Resilience(OPPORTUNITY)◆
EBITDA margin 23.7% (higher end of guidance) despite Middle East cost impacts, volume-led 8% revenue growth
- Dabur/AGM Catalyst↓(OPPORTUNITY)◆
51st AGM Aug 6 via VC, post-results conference call May 7 recording available for deep dive
- Radico/Concall Access↓(OPPORTUNITY)◆
Q4/FY26 call recording live, opportunity to gauge premiumization/alcohol demand trends vs UBL
- Emami/Remaining Stake↓(OPPORTUNITY)◆
Option to buy balance 40% in 4.5 yrs tranches on performance, upside if turnaround succeeds
- UBL/Earnings Review(OPPORTUNITY)◆
Q4 FY26 call recording (ID 10042265) for beer volume/margin insights amid sector catalysts
Sector Themes(6)
- Earnings Momentum Build◆
5/18 filings (HUL, Britannia, UBL, Radico, Dabur) disclose/post Q4/FY26 results/calls; avg FY revenue growth 7.2% YoY (HUL 8%, Britannia 6.7%), but Q4 QoQ mixed (-5% Britannia); implies steady volumes, watch May 15/21 boards (Kilitch/ITC) for confirmation
- Dividend Consistency◆
3 cos (Dabur Rs 5.50/550%, Britannia Rs 90.50, ITC pending) prioritize payouts with record dates Jul (17/31), AGMs Aug; YoY stable policy signals cash generation > reinvestment in mature FMCG
- Strategic M&A in Beauty◆
Emami's 2 filings on Rs 321 Cr IncNut buy (60% stake, personalized BPC) despite target -13% avg YoY revenue drop; echoes HUL portfolio x4 growth, theme of D2C/digital acquisitions at <2x sales multiples
- Cost & Governance Stability◆
Unmodified audit opinions (Dabur, Britannia), immaterial JV loss (Dabur); employee costs +17% YoY (Britannia) from labor codes, but margins hold (HUL 23.7%); neutral sentiment 70% filings reflects procedural strength
- Catalyst Clustering May-Jul◆
8 events (board meets May 15/21, record dates Jul, AGMs Aug, deal closes Jun); HUL USG acceleration (5% FY vs 2% prior) vs Britannia Q4 dip flags volume divergence, alpha in pre-event positioning
- Simplification & Expansion◆
ITC merger (Jun 1 effective) + Emami external buy; 2/18 filings show inorganic growth, contrasts organic USG focus (HUL +5%), potential for diversified revenue in FMCG slowdowns
Watch List(8)
May 21 for FY26 results + dividend; no figures yet, monitor segment revenue/cash flows vs HUL/Britannia growth [May 21, 2026]
May 15 for FY26 audited results; trading window closed since Apr 1, watch for pharma-FMCG overlap metrics [May 15, 2026]
Jul 17 for Rs 5.50 dividend; book closure Jul 20-24, AGM Aug 6; post-concall May 7 insights on FY27 guidance [Jul 17, 2026]
Completion within 30 days (~Jun 6); monitor integration of declining turnover asset (Vedix/SkinKraft) [Jun 6, 2026]
Jul 31 record for Rs 90.50 dividend, AGM Aug 7; Q4 weakness (-5% QoQ) vs FY strength, guidance update key [Jul 31, 2026]
Jun 1 for Sresta/Wimco; track EPS impact, new UAE/USA subs addition post-NCLT sanction [Jun 1, 2026]
- HUL/Portfolio Momentum👁
Post-Q4 7% USG (highest 12Q), watch FY27 guidance in future calls amid Middle East costs [Ongoing]
Review Q4/FY26 recordings for alcohol sub-sector volumes vs broader FMCG (HUL/Britannia) [Immediate]
Filing Analyses(18)
07-05-2026
United Breweries Limited has released the audio recording of its Earnings Call for the quarter ended March 31, 2026 (Q4 FY2026), conducted on May 06, 2026. The recording is accessible on the company's website via weblink (Record ID: 10042265) in compliance with SEBI regulations. This follows prior intimations dated April 27, 2026, and May 05, 2026, regarding the call and investor presentation.
- ·Scrip Code: 532478
- ·Symbol: UBL
- ·URL: https://ccreservations.com/recordings/select_recordings.php (Record ID: 10042265)
- ·Corporate Identity Number: L36999KA1999PLC025195
- ·Registered Office: UB Tower, UB City, #24, Vittal Mallya Road, Bengaluru – 560 001
07-05-2026
ITC Limited announced a Board of Directors meeting scheduled for Thursday, May 21, 2026, to approve the Audited Standalone and Consolidated Financial Results for the quarter and twelve months ended March 31, 2026, including segment-wise revenue, results, assets, liabilities, balance sheet, and cash flows. The board will also consider and recommend a final dividend for the financial year ended March 31, 2026. This notice is issued in compliance with Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, with no financial figures or performance metrics disclosed yet.
- ·Meeting convened inter alia for the specified approvals.
- ·cc to Securities Exchange Commission and Societe de la Bourse de Luxembourg.
07-05-2026
Emami Limited executed a Share Subscription and Purchase Agreement on May 7, 2026, to acquire a stake in IncNut Digital Private Limited. This follows their earlier intimation on the same date under Regulation 30 of SEBI (LODR) Regulations, 2015. Full details compliant with SEBI Master Circular dated January 30, 2026, are available on the company's website at www.emamiltd.in.
- ·Scrip Codes: EMAMILTD (NSE), 531162 (BSE)
07-05-2026
Dabur India Limited's Board of Directors approved the audited consolidated and standalone financial results for the quarter and financial year ended March 31, 2026, with an unmodified opinion from the statutory auditors. The Board recommended a final dividend of Rs. 5.50 per equity share (550% on face value of Re. 1) for shareholder approval. Notably, the Group's share of net loss in a joint venture was ~1.80 crores, though deemed not material to the Group.
- ·Board meeting held on May 07, 2026, commencing at 02:00 P.M. and concluding at 04:22 P.M.
- ·51st Annual General Meeting fixed for Thursday, August 06, 2026, at 3.00 P.M. IST via Video Conferencing/Other Audio-Visual Means.
- ·Financial results publication in Mint (English) and Deshbandhu (Hindi) on May 08, 2026.
07-05-2026
Dabur India Limited's Board recommended a final dividend of ₹5.50 per share (550%) for FY 2025-26. The record date is July 17, 2026, with book closure from July 20 to July 24, 2026 (both days inclusive), ahead of the AGM on August 06, 2026. Dividend payment, if approved at the AGM, will be made on or before September 04, 2026.
- ·Filing reference: SEC/SE/2026-27
- ·BSE Scrip Code: 500096; NSE Scrip Symbol: DABUR
07-05-2026
Dabur India Limited's Board approved audited consolidated and standalone financial and segment-wise results for Q4 and FY ended March 31, 2026, with an unmodified auditor's opinion from G. Basu & Co. The Board recommended a final dividend of Rs. 5.50 per equity share (550% on Re. 1 face value) for FY 2025-26, subject to shareholder approval. The 51st AGM is scheduled for August 06, 2026, at 3:00 PM IST via Video Conferencing/Other Audio-Visual Means.
- ·Statutory auditors issued unmodified opinion on consolidated and standalone financial results.
- ·Financial results available on www.nseindia.com, www.bseindia.com, and www.dabur.com.
- ·QR code and webpage details to be published in Mint (English) and Deshbandhu (Hindi) on May 08, 2026.
- ·Joint venture financial information considered not material to the Group.
07-05-2026
Dabur India Limited's Board approved audited consolidated and standalone financial and segment-wise results for the quarter and FY ended March 31, 2026, with an unmodified auditor's opinion; the results are available on company and exchange websites. The Board recommended a final dividend of ₹5.50 per equity share (550% on Re. 1 face value) for FY 2025-26, subject to AGM approval. The 51st AGM is fixed for August 6, 2026, at 3:00 PM IST via video conferencing/other audio-visual means.
- ·Statutory auditors issued unmodified opinion on consolidated and standalone results.
- ·Financial results to be published in Mint (English) and Deshbandhu (Hindi) on May 08, 2026.
- ·Joint venture financial information unaudited but approved as not material by management.
- ·Board meeting held on May 07, 2026, from 2:00 PM to 4:22 PM IST.
07-05-2026
Dabur India Limited's Board approved the audited consolidated and standalone financial results for the quarter and FY ended March 31, 2026, with an unmodified auditor opinion from G. Basu & Co. The Board recommended a final dividend of Rs. 5.50 per equity share (550% on Re. 1 face value) for FY 2025-26, subject to shareholder approval. The 51st AGM is scheduled for August 06, 2026, via VC/OAVM; note the Group's share of JV net loss was ~1.80 crores (deemed immaterial).
- ·Board meeting held on May 07, 2026, from 02:00 P.M. to 04:22 P.M. IST.
- ·Financial results to be published in Mint (English) and Deshbandhu (Hindi) on May 08, 2026.
- ·Results available on www.nseindia.com, www.bseindia.com, and www.dabur.com.
07-05-2026
Dabur India Limited's Board of Directors, in its meeting on May 07, 2026, recommended a final dividend of ₹5.50 per share (550%) for FY 2025-26. The record date for ascertaining eligible shareholders is July 17, 2026, with book closure from July 20 to July 24, 2026 (both days inclusive). The AGM is scheduled for August 06, 2026, with dividend payment on or before September 04, 2026, if approved by shareholders.
- ·BSE Scrip Code: 500096
- ·NSE Scrip Symbol: DABUR
- ·CIN: L24230DL1975PLC007908
07-05-2026
Dabur India Limited's Board of Directors, in its meeting on May 07, 2026, recommended a final dividend of ₹5.50 per share (550%) for FY 2025-26. The record date for ascertaining eligible shareholders is July 17, 2026, with book closure from July 20 to July 24, 2026 (both days inclusive). The AGM is scheduled for August 06, 2026, with dividend payment on or before September 04, 2026, if approved by shareholders.
- ·BSE Scrip Code: 500096
- ·NSE Scrip Symbol: DABUR
- ·CIN: L24230DL1975PLC007908
07-05-2026
Dabur India Limited has shared the link to the audio recording of the Investors’ Conference Call held on May 07, 2026, following the declaration of financial results for Q4 and FY 2025-26 ended March 31, 2026. The disclosure complies with Regulation 30 of SEBI (LODR) Regulations, 2015. No specific financial metrics or performance details are provided in this filing.
- ·Audio recording link: https://www.dabur.com/Investors/Financial%20Information/Results/2025-26/Q4/10042002.mp3
- ·BSE Scrip Code: 500096; NSE Scrip Symbol: DABUR
- ·CIN: L24230DL1975PLC007908
07-05-2026
Radico Khaitan Limited has disclosed the availability of the audio recording of the earnings conference call held on May 07, 2026, for the audited financial results of the quarter and financial year ended March 31, 2026. The recording is accessible on the company's website pursuant to Regulation 30 of the Listing Regulations. No specific financial metrics were detailed in this disclosure.
- ·Weblink: https://radicokhaitan.com/wp-content/uploads/2026/05/RKL-Q4-FY2026-Concall-Recording.mp3
- ·Scrip Code: 532497
- ·Symbol: RADICO
- ·CIN No.: L26941UP1983PLC027278
- ·Reference letter: RKL/SX/2026-27/06 dated April 29, 2026
07-05-2026
Hindustan Unilever Limited delivered 8% consolidated revenue growth in Q4 FY26 with 7% underlying sales growth (USG, highest in 12 quarters), driven primarily by volumes across all segments, amid stable demand but navigating Middle East crisis impacts on costs. EBITDA grew 6% YoY with a 23.7% margin at the higher end of guidance, while PAT before exceptional items rose 4% to Rs. 2,711 crores. FY26 turnover reached Rs. 63,763 crores with 5% USG (4% UVG), accelerating from 2% USG in FY25, supported by portfolio transformation and execution improvements.
- ·Increased direct coverage by 2 lakh outlets in General Trade FY26.
- ·Beauty & Wellbeing portfolio quadrupled over the last year.
- ·Home Care liquids portfolio crossed Rs. 4,000 crores turnover with double-digit growth and market share gains.
- ·Lifestyle Nutrition delivered four consecutive quarters of positive UVG, double-digit in H2 FY26.
07-05-2026
Board approved audited consolidated FY26 financial results with revenue from operations up 6.7% YoY to ₹19,151.59 Cr and net profit up 16.5% YoY to ₹2,537.01 Cr; however, Q4 revenue declined 5.1% QoQ to ₹4,718.92 Cr from ₹4,969.82 Cr, and other operating revenues fell 28.1% YoY to ₹293.38 Cr. Recommended final dividend of ₹90.50 per equity share (face value ₹1) subject to AGM approval on 7th August 2026 (record date 31st July 2026), with unmodified auditor opinion. Employee benefits expense rose 16.9% YoY to ₹823.80 Cr amid labour code impacts.
- ·Audited standalone FY26 net profit ₹2,561.72 Cr.
- ·Total assets grew to ₹9,731.94 Cr from ₹8,838.55 Cr.
- ·Net cash from operating activities ₹2,611.60 Cr (up from ₹2,490.62 Cr).
- ·Current borrowings increased to ₹1,071.72 Cr from ₹511.83 Cr.
- ·Register of Members to close from 1st August to 7th August 2026.
- ·Board meeting held 7th May 2026 from 3:30 PM to 7:15 PM IST.
07-05-2026
Emami Limited's Board approved the execution of a Share Subscription and Purchase Agreement to acquire 60% stake on a fully diluted basis in IncNut Digital Private Limited for an aggregate consideration of up to ₹321 Cr, with completion expected within 30 days subject to customary conditions. IncNut Digital, along with its subsidiary IncNut Lifestyle Retail Private Limited, operates in the personalised beauty and personal care segment through brands Vedix and SkinKraft, reinforcing Emami's presence in high-growth BPC areas. However, the target's consolidated turnover has declined YoY from ₹231.9 Cr in FY 2022-23 to ₹196.5 Cr in FY 2023-24 (-15.3%) and further to ₹175.1 Cr in FY 2024-25 (-10.9%).
- ·IncNut Digital incorporated on 4th July 2011 in Telangana; IncNut Lifestyle Retail Private Limited incorporated on 21st May 2018 in Telangana.
- ·Transaction not a related party transaction; no promoter/group interest.
- ·No governmental or regulatory approvals required.
- ·Cash consideration; remaining 40% stake to be acquired in two tranches over next 4.5 years based on performance matrix.
- ·Board meeting held and concluded on 7th May 2026 at 11:10 a.m.
07-05-2026
Emami Limited has entered into a definitive agreement to acquire a 60% stake (on a fully diluted basis) in IncNut Digital Pvt. Ltd., operator of Vedix and SkinKraft brands, for Rs.321cr., with performance-linked adjustments over a 24-month period and plans to acquire the remaining stake within 4.5 years in two tranches based on future performance. This move strengthens Emami's presence in the high-growth personalised beauty and personal care segment, complementing brands like The Man Company and Brillare. Executives highlighted the strategic fit for scaling innovation and market reach.
- ·Emami founded in 1974.
- ·IncNut Digital founded in 2011 and based in Hyderabad.
- ·Emami's past acquisitions include Zandu (2008), Kesh King (2015), Creme 21 (2019), and Dermicool (2022).
07-05-2026
Kilitch Drugs (India) Limited has intimated that a Board of Directors meeting will be held on May 15, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Pursuant to SEBI regulations, the trading window has been closed effective April 1, 2026, and will reopen 48 hours after the financial results are disclosed to the stock exchanges.
- ·Scrip Code: BSE - 524500, NSE - KILITCH
- ·Company CIN: L24239MH1992PLC066718
- ·Pursuant to Regulation 29 of SEBI (LODR) Regulations, 2015
07-05-2026
ITC Limited announced that the Scheme of Amalgamation of subsidiaries Sresta Natural Bioproducts Private Limited and Wimco Limited with the Company has been sanctioned by the National Company Law Tribunal, Kolkata and Hyderabad Benches, with certified orders filed on May 7, 2026. The Effective Date is June 1, 2026, on which Sresta and Wimco will dissolve without winding up and cease to be subsidiaries, while Sresta's subsidiaries—Sresta Global FZE (UAE) and Fyve Elements LLC (USA)—will become direct wholly owned subsidiaries of ITC. All conditions in Clause 30.1 of the Scheme have been fulfilled, with Appointed Dates of June 13, 2025 for Sresta and April 1, 2025 for Wimco.
- ·Previous letter reference: August 1, 2025
- ·Orders filed with Registrar of Companies, West Bengal (for Kolkata Bench) and Telangana (for Hyderabad Bench)
Get daily alerts with 12 investment signals, 8 risk alerts, 10 opportunities and full AI analysis of all 18 filings
More from: BSE FMCG Sector Regulatory Filings
🇮🇳 More from India
View all →May 01, 2026
India Pre-Market Regulatory Roundup — May 01, 2026
India Pre-Market Regulatory Roundup
May 01, 2026
India Quarterly Results BSE NSE Announcements — May 01, 2026
India Quarterly Results BSE NSE Announcements
May 01, 2026
India Upcoming Corporate Actions BSE NSE — May 01, 2026
India Upcoming Corporate Actions BSE NSE
May 01, 2026
BSE Auto Sector Regulatory Filings — May 01, 2026
BSE Auto Sector Regulatory Filings